Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phagocyte activation describes the state in which immune cells known as phagocytes (macrophages, neutrophils, dendritic cells, monocytes) become functionally primed or stimulated, typically in response to infectious or inflammatory signals. This priming occurs via the recognition of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) through pattern-recognition receptors (PRRs), Fcγ receptors, complement receptors, or other opsonic and non-opsonic receptors. Upon activation, phagocytes increase surface expression of adhesion molecules and phagocytic receptors, enhance their microbicidal and metabolic activity, produce inflammatory cytokines, and migrate to sites of infection or injury, where they ingest and degrade pathogens and cell debris. Overactivation can lead to collateral tissue damage, while insufficient activation compromises host defense.
Inhibition or upregulation of surface receptors (FcγR, complement receptors); modulation of intracellular signaling pathways (e.g., Rho GTPase, PI3K, PKC); modulation of cytokine production; and suppression/activation of actin cytoskeletal rearrangement.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phagocyte activation.